eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
1/2020
vol. 16
 
Share:
Share:
more
 
 
Experimental research

The effects of hyperbilirubinaemia on synaptic plasticity in the dentate gyrus region of the rat hippocampus in vivo

Li Yang
,
De Wu
,
Baotian Wang
,
Xiaosong Bu
,
Jing Zhu
,
Jiulai Tang

Arch Med Sci 2020; 16 (1): 200–204
Online publish date: 2019/10/14
Article file
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 

Introduction

Bilirubin is an oxidative end product of heme catabolism and is excreted by liver after glucuronidation by hepatic uridine diphosphate glucuronosyltransferase [1]. Hyperbilirubinaemia remains one of the most frequent clinical diagnoses in the neonatal period, and more than 60% of newborns develop clinical jaundice in the first week of life [2, 3]. Severe hyperbilirubinaemia may progress to acute kernicterus or bilirubin encephalopathy with a significant risk of mortality in newborns [4–6]. Moreover, recently hyperbilirubinaemia has emerged as a significant risk factor for non-syndromic auditory neuropathy due to dys-synchrony in the auditory nerve or brainstem auditory pathways, causing auditory processing problems or neural, not sensory, hearing loss [7].
Total bilirubin is composed of conjugated and unconjugated bilirubin [8]. Unconjugated bilirubin is a potent neurotoxin, which, by crossing the blood‒brain barrier, may injure neural cells. Once in the brain, bilirubin has been reported to lead to impaired myelination, astrocyte and microglia activation, and neuronal cell death [9]. Except for the traditional recognised areas of fulminant injury to the globus pallidus as observed in infants with kernicterus, the hippocampus, one of the important regions of brain for memory and learning function [10], is a major target of bilirubin in the brain [11].
A previous study has indicated that exposure of hippocampal slice cultures to unconjugated bilirubin leads to long-term depression (LTD) induction and an impairment of CA1 long-term potentiation (LTP) in a time- and concentration-dependent manner [1]. LTP is a form of synaptic plasticity that is believed to form the cellular basis for memory and learning [12]. It was suggested that such deficits in LTP may underlie some cognitive impairments associated with unconjugated bilirubin exposure. Therefore, investigations of hyperbilirubinaemia-induced impairment of synaptic plasticity are of great importance to the mechanism underlying the effects of hyperbilirubinaemia on cognitive impairment.
Herein we aim to investigate the effect of hyperbilirubinaemia on synaptic plasticity in the dentate gyrus (DG) region of hippocampal rats. Seven-day-old healthy SD rats were randomly divided into a control group and an experiment group. The I/O functions, paired-pulse ratio (PPR), excitatory postsynaptic potential (EPSP), and population spike (PS) amplitude were measured in the DG area of the two groups of rats in response to stimulation applied to the lateral perforant path.

Material and methods

Experimental animals and treatment

Healthy Sprague Dawley rat pups (seven days old) were used in the study. According to Vannucci et al. [13], the development of the brain of a rat at this age is histologically similar to that of a 32- to 34-week gestation human newborn infant. Forty female rats (15.6–19.4 g) were obtained from the Experimental Animal Centre of Anhui Province (Animal license: SCXK, 2005–001). The rats were fasted for 12 h and divided into two groups (n = 20 in each group). The first group was injected (i.p.) with bilirubin solution. Bilirubin solution was obtained from Sigma (St Louis, MO) and purified according to the method of McDonagh [14]. Bilirubin was dissolved in 0.5 M NaOH and was prepared immediately before use under light protection to avoid photodegradation; the pH was restored to 8.5 by addition of 0.5 M HCl. The study was approved by AnHui Medical University Ethics Committee. Rats in the experiment group were injected (i.p.) with 0.342 M bilirubin solution based on the previous study [15]. The other 20 normal rats were injected with normal saline and used as the control group. The rat model of hyperbilirubinaemia was validated after 48 h; in our study, 16 rats were identified as the successful model of hyperbilirubinemia. At the age of 80–100 days, the animals were utilised for extracellular recording in the area of the DG of the hippocampus.

Stimulation and recording

Rats were anaesthetised with urethane (1.5 g/kg, i.p.), and the head was fixed in a stereotaxic head-holder (under deep ether anaesthesia). A concentric bipolar stimulating electrode (0.25 mm outer diameter, 0.75 mm tip separation; Rhodes Medical Instruments, Woodland Hills, CA) was placed in the lateral perforant path.
A glass micropipette recording electrode (3–5 µm tip diameter, 1–3 MΩ, co-ordinates: 3.8 mm posterior to bregma, 2.5 mm lateral to the midline) was lowered into the DG until the maximal response was observed (3.0–3.5 mm ventral). Glass micropipettes filled with 2 M NaCl were used for extracellular recordings.

I/O function

I/O curves were generated by systematic variation of the stimulus current (0.1–1.0 mA) in order to evaluate synaptic potency as previously described [16]. Stimulus pulses were delivered at 0.125 Hz.

Paired-pulse ratio

The paired-pulse ratio (PPR) was evaluated by increasing the inter-pulse intervals (IPIs, 10–400 ms) as previously described [16]. The stimulus current intensity was adjusted at an intensity yielding about 50% of the maximal amplitude of the population spike (PS). Stimulus pairs were delivered at 0.05 Hz.

Long-term potentiation

Long-term potentiation were recorded as previously described [16]. The stimulus intensity selected for baseline measurements was adjusted to yield about 40% of its maximal amplitude. Baseline recordings were obtained for 30 min at 8-s intervals (0.125 Hz), followed by application of the high-frequency stimulation (HFS: 250 Hz, 1 s) and a post-tetanic recording period of 1 h with a single pulse.

Data analysis

All data were shown as the mean ± SEM. Data were recorded using an Igor Pro 6.2 (Wave Metrics, OR) and analysed with Origin 7.5 software (Origin Lab, MA). The PS amplitude and the EPSP slope was measured as previously described [12]. Two-way analysis of variance (ANOVA) followed by 2 test was performed to compare the difference between the groups. P < 0.05 was considered as statistically significant.

Results

I/O functions

Figure 1 illustrates the I/O curves in the DG, which were measured as EPSP slope (A) and PS amplitude (B) before induction of LTP in control and hyperbilirubinaemia rats. Compared with those of the control rats, the current-voltage curves of both EPSP slope and PS amplitude in the experimental rats were significantly depressed (EPSP: F = 11.539, p < 0.01; PS: F = 102.224, p < 0.01). The result suggests that hyperbilirubinaemia significantly depressed the basic synaptic transmission.

Paired-pulse reactions

To examine the effect of hyperbilirubinaemia on the short-term synaptic plasticity of rats, we measured the PPR of the PS amplitude. The results in Figure 2 show the PPR of the PS amplitude in the control and experiment groups. The PS2/PS1 is defined as a PPR ratio to quantify the effect as enhancement or inhibition of the second response relative to the first. The peak facilitation (the values of the extreme point of the curve) and the facilitation period are used to describe the differences in the two groups. The average peak facilitation was 187 ±16% in the control and 164 ±18% in the experiment group (F = 21.054, p < 0.01).
The facilitation period duration of PS was 155 ms in the experimental rats, which was less than that of the controls (235 ms). This result shows that hyperbilirubinaemia impairs paired-pulse facilitation (PPF) significantly.

Long-term potentiation

The results in Figure 3 show the amplitudes of LTP on both the EPSP slope (A) and the PS amplitude (B) in the control and experimental groups. In the control group, the LTP amplitudes were 140 ±3.5% and 242 ±6%, when estimated from the EPSP slope and PS amplitude, respectively, which were significantly depressed to 124 ±3.4% (EPSP slope, F = 70.489, p < 0.01) and 138 ±8.6% (PS amplitude, F = 253.46, p < 0.01) in the experiment group. These results demonstrated that hyperbilirubinaemia induced a deficit of LTP in the DG area of the hippocampus.

Discussion

This study suggests that hyperbilirubinaemia induces impairment of synaptic plasticity in the rat DG area in vivo, including PPR, I/O function, and LTP. I/O function reflects the basal synaptic response, which can reflect not only the postsynaptic receptor response, but also the level of presynaptic neurotransmitter release [12]. PPR is a short-term synaptic plasticity [17] and is a facilitation of a second response when a synapse is stimulated twice with a short interval (20–400 ms) [12]. LTP is an electrophysiological model of activity-dependent plasticity that embodies the cellular components of information storage at the synaptic level, and is widely accepted as a primary mechanism of memory [18, 19]. Previous novel findings also showed that short-term exposure to bilirubin can inhibit the induction of LTPs in the hippocampus [20]. It is well-accepted that memory is intimately associated with the plasticity of neuronal synapses in the hippocampus and a decline in cognitive function directly correlates with loss of synapses [21]. Thus, our study may indicate that hyperbilirubinaemia has an effect on cognitive impairment.
Many clinical investigations have suggested a close association between high total serum bilirubin levels and the neurodevelopmental risks in newborns [22–24]. A recent study reported the 30-year results of a prospective follow-up study on a birth cohort of full-term and normal-weight newborns with hyperbilirubinaemia, and concluded that 45% of the cases identified with neonatal hyperbilirubinaemia showed at least one neurobehavioral disability at the age of nine years (significantly higher than rates in controls), and these difficulties appeared to continue into adulthood [25]. Also, an earlier study suggested that that prolonged exposure of clinically relevant concentrations of unconjugated bilirubin exposure impairs the induction of hippocampal CA1 LTP and LTD in rat organotypic slice cultures [1]. Hansen et al. [26] indicated that the effect of bilirubin on rat hippocampal slices consists of a gradual and reversible decrease in synaptic transmission by causing the presynaptic fibre volley (PV)/EPSP curve to shift to the right while the EPSP/population spike (PS) curve shifted to the left.
The molecular mechanism was explored in several studies. Li et al. reported that bilirubin facilitates presynaptic glutamate release and enhances glutamatergic synaptic transmission by activating postsynaptic AMPA and NMDA receptors, which results in neuronal hyperexcitation [27]. Another study indicated that the increased intracellular calcium concentration [Ca2+]i, the perturbations of plasma, mitochondrial, and/or endoplasmic reticulum membranes or mitochondrial energy failure are likely to be linked temporally and spatially in the pathogenesis of bilirubin induced neuronal injury [28]. Moreover, a previous study summarised that low levels of free bilirubin may promote programmed neuronal death, corresponding to an apoptotic process that requires the participation of NMDA receptors and involves caspase activation, along with bilirubin-induced inhibition of protein kinase C activity [29]. Whether bilirubin-induced depression of synaptic transmission is due to apoptotic neurodegeneration requires further investigation.
To sum up, these findings suggest that hyperbilirubinaemia could induce impairment of synaptic plasticity in the rat DG area in vivo, including I/O function, PPR, and LTP, which may be closely related to cognitive impairment.

Funding

This research was supported by grants from the National Natural Science Foundation of China [No. 81472167].

Conflict of interest

The authors declare no conflict of interest.

References

1. Chang FY, Lee CC, Huang CC, Hsu KS. Unconjugated bilirubin exposure impairs hippocampal long-term synaptic plasticity. PLoS One 2009; 4: e5876.
2. Dennery PA, Seidman DS, Stevenson DK. Drug therapy: Neonatal hyperbilirubinemia. N Engl J Med 2001; 344: 581-90.
3. Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. Am Fam Physician 2014; 89: 873-8.
4. Slusher TM, Vreman HJ, Mclaren DW, Lewison LJ, Brown AK, Stevenson DK. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995; 126: 102-8.
5. English M, Ngama M, Musumba C, et al. Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child 2003; 88: 438-43.
6. Hameed NN, Na’Ma AM, Vilms R, Bhutani VK. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 2011; 100: 57-63.
7. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 2003; 29: 410-21.
8. Rose J, Vassar R. Movement disorders due to bilirubin toxicity. Semin Fetal Neonatal Med 2014; 20: 20-5.
9. Brites D. Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights. Semin Perinatol 2011; 35: 114-20.
10. Zheng X, Zhou J, Xia Y. The role of TNF- in regulating ketamine-induced hippocampal neurotoxicity. Arch Med Sci 2015; 11: 1296-302.
11. Bhutani VK, Wong R. Bilirubin-induced neurologic dysfunction (BIND). Semin Fetal Neonatal Med 2015; 20: 1.
12. Hu P, Wang M, Chen WH, et al. Quercetin relieves chronic lead exposure-induced impairment of synaptic plasticity in rat dentate gyrus in vivo. Naunyn Schmiedebergs Arch Pharmacol 2008; 378: 43-51.
13. Vannucci RC, Connor JR, Mauger DT, et al. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 1999; 55: 158-63.
14. Mcdonagh AF. ChemInform Abstract: BILE PIGMENTS: BILATRIENES AND 5,15-BILADIENES. ChemInform 1980; 11.
15. Wei W, De WU, Zhang C, Tang JL. Influence of hyperbilirubinemia on dentate gyrus of hippocampal synaptic plasticity in rats. J Appl Clin Pediatric 2010.
16. Wang M, Chen WH, Zhu DM, She JQ, Ruan DY. Effects of carbachol on lead-induced impairment of the long-term potentiation/depotentiation in rat dentate gyrus in vivo. Food Chem Toxicol 2007; 45: 412-8.
17. Magelby BK. Short-term synaptic plasticity. Ann Rev Neurosci 2010; 12: 13-31.
18. Bliss TV, Collingridge GL. Asynaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-9.
19. McNaughton BL. The mechanism of expression of long-term enhancement of hippocampal synapses: current issues and theoretical implications. Annu Rev Physiol 1993; 55: 375-96.
20. Zhang L, Liu W, Tanswell AK, Luo X. The effects of bilirubin on evoked potentials and long-term potentiation in rat hippocampus in vivo. Pediatr Res 2003; 53: 939-44.
21. Chang R, Geng Z, Zhu Q, Song Z, Wang Y. Proton magnetic resonance spectroscopy reveals significant decline in the contents of N-acetylaspartylglutamate in the hippocampus of aged healthy subjects. Arch Med Sci 2017; 13: 124-37.
22. Reading R. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. Child Care Health Develop 2006; 354: 1889-900.
23. Koziol LF, Budding DE, Chidekel D. Hyperbilirubinemia: subcortical mechanisms of cognitive and behavioral dysfunction. Pediatr Neurol 2013; 48: 3-13.
24. Hansen RL, Hughes GG, Ahlfors CE. Neonatal bilirubin exposure and psychoeducational outcome. J Dev Behav Pediatr 1991; 12: 287-93.
25. Hokkanen L, Launes J, Michelsson K. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates-a 30 year prospective follow-up study. Peer J 2014; 2: e294.
26. Hansen TWR, Paulsen O, Gjerstad L, Bratlid D. Bilirubin reversibly reduces synaptic transmission in rat hippocampal slices. Pediatr Res 1985; 19: 1082.
27. Li CY, Shi HB, Song NY, Yin SK. Bilirubin enhances neuronal excitability by increasing glutamatergic transmission in the rat lateral superior olive. Toxicology 2011; 284: 19-25.
28. Watchko JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med 2006; 8: 513-29.
29. Grojean S, Koziel V, Vert P, Daval JL. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 2000; 166: 334-41.
Copyright: © 2019 Termedia & Banach. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe